A Patient Perspective on Coverage Challenges on JHLT: The Podcast
For the first time, JHLT welcomes a patient as a guest on the podcast.
Heart transplant recipient and patient advocate Payton Herres joins the podcast for a discussion about her recent perspective piece in JHLT, "When coverage is not access: A heart transplant recipient's perspective on everolimus, U.S. Food and Drug Administration labeling, and the problem of 'ghost approval.'"
Listen Now
Stream the podcast on Spotify, Amazon, iTunes, and anywhere else you get podcasts.
In this compelling, moving discussion, Payton shares:
- Her treatment story—from her congenital diagnoses to her life-changing transplant—and her donor's story
- The difference between coverage and access—and how FDA labeling affected her access to an important component of her care
- What she wishes clinicians understood about long-term care of transplant patients
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you’re an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
Don’t already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation for a free subscription, or subscribe today at www.jhltonline.org.
Listen Now
Stream the podcast on Spotify, Amazon, iTunes, and anywhere else you get podcasts.


